Practical Aspects of Delivering Radiation for Polymetastatic Disease

Area of Science:

• Radiation Oncology
• Medical Oncology
• Cancer Research

Background:

• Polymetastatic cancer treatment traditionally relies on systemic therapies with radiotherapy in a palliative role.
• Stereotactic ablative radiotherapy (SABR) shows promise for widespread polymetastatic disease, extending from oligometastatic efficacy.
• Low-dose radiotherapy (LDRT) is explored for its immunomodulatory potential to enhance immunotherapy.

Purpose of the Study:

• To provide an evidence-informed overview of SABR and LDRT strategies in polymetastatic cancer.
• To address clinical, technical, and logistical challenges in integrating SABR and LDRT.
• To offer a practical resource for safe and effective implementation in complex cases.

Main Methods:

• Review of recent clinical trials and data on SABR in polymetastatic settings.
• Exploration of LDRT as an immunomodulatory approach with systemic immunotherapy.
• Analysis of radiotherapy workflow adaptations for SABR and LDRT implementation.
• Inclusion of real-world case examples of patients with widespread polymetastatic disease.

Main Results:

• SABR is a feasible and safe option for select patients with widespread polymetastatic disease.
• LDRT demonstrates potential as an immunomodulatory strategy to augment immunotherapy.
• Integration of SABR/LDRT requires tailored protocols and workflow adaptations for safety and efficacy.
• Case examples illustrate successful implementation in complex clinical scenarios.

Conclusions:

• SABR and LDRT represent evolving radiotherapy strategies for polymetastatic cancer.
• Successful integration necessitates addressing specific clinical, technical, and logistical challenges.
• This resource aims to guide clinicians and multidisciplinary teams in adopting these advanced techniques.
• The implementation of SABR and LDRT can enhance therapeutic outcomes for patients with widespread metastatic disease.